{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:13:58Z","timestamp":1789888438595,"version":"4.0.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.seizure.2019.02.017","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T19:02:44Z","timestamp":1550862164000},"page":"11-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy"],"prefix":"10.1016","volume":"67","author":[{"given":"Siew Mei","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"November 22","key":"10.1016\/j.seizure.2019.02.017_bib0005","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"January Database issue","key":"10.1016\/j.seizure.2019.02.017_bib0010","doi-asserted-by":"crossref","first-page":"D1039","DOI":"10.1093\/nar\/gkx1039","article-title":"VarCards: an integrated genetic and clinical database for coding variants in the human genome","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"June 6","key":"10.1016\/j.seizure.2019.02.017_bib0015","first-page":"2230","article-title":"Leaky Ca2+ release channel\/ryanodine receptor 2 causes seizures and sudden cardiac death in mice","volume":"118","author":"Lehnart","year":"2008","journal-title":"J Clin Invest"},{"issue":"November 11","key":"10.1016\/j.seizure.2019.02.017_bib0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2004.028993","article-title":"Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients","volume":"42","author":"Postma","year":"2005","journal-title":"J Med Genet"},{"issue":"July 7","key":"10.1016\/j.seizure.2019.02.017_bib0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.humpath.2005.04.019","article-title":"Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates","volume":"36","author":"D\u2019Amati","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.seizure.2019.02.017_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fphys.2017.00443","article-title":"The N-terminal region of the ryanodine receptor affects channel activation","volume":"8","author":"Faltinova","year":"2017","journal-title":"Front Physiol"},{"issue":"February 6","key":"10.1016\/j.seizure.2019.02.017_bib0035","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1074\/jbc.M210962200","article-title":"Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor)","volume":"278","author":"Masumiya","year":"2003","journal-title":"J Biol Chem"},{"issue":"August 33","key":"10.1016\/j.seizure.2019.02.017_bib0040","first-page":"E4895","article-title":"Leaky RyR2 channels unleash a brainstem spreading depolarization mechanism of sudden cardiac death","volume":"113","author":"Aiba","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December 12","key":"10.1016\/j.seizure.2019.02.017_bib0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/cns.12860","article-title":"Novel West syndrome candidate genes in a Chinese cohort","volume":"24","author":"Peng","year":"2018","journal-title":"CNS Neurosci Ther"},{"issue":"July 7","key":"10.1016\/j.seizure.2019.02.017_bib0050","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/0883073809343722","article-title":"Cardiac channel molecular autopsy for sudden unexpected death in epilepsy","volume":"25","author":"Johnson","year":"2010","journal-title":"J Child Neurol"},{"issue":"January Supple 1","key":"10.1016\/j.seizure.2019.02.017_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/epi.13232","article-title":"Sudden unexpected death in epilepsy genetics: molecular diagnostics and prevention","volume":"57","author":"Goldman","year":"2016","journal-title":"Epilepsia"},{"issue":"January","key":"10.1016\/j.seizure.2019.02.017_bib0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.seizure.2016.10.001","article-title":"The heart of epilepsy: current views and future concepts","volume":"44","author":"Shmuely","year":"2017","journal-title":"Seizure"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118306484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118306484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:51:34Z","timestamp":1761011494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118306484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":12,"alternative-id":["S1059131118306484"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.02.017","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}